Literature DB >> 1697491

Permanently implanted urethral stent for prostatic obstruction in the unfit patient. Preliminary report.

C R Chapple1, E J Milroy, D Rickards.   

Abstract

We describe the use of a new urethral stent implanted into 12 patients with prostatic outflow obstruction. All were in a high risk group for surgery and 11 were treated successfully, with a follow-up of 1 to 11 months (median 9). The majority of patients were satisfied with the procedure, which provided a quick, safe and effective alternative to conventional surgical treatment. The stent, woven from fine stainless steel in the form of a tubular mesh, was inserted via a delivery device using combined ultrasound and endoscopic control under local anaesthesia. The procedure was well tolerated, the stent becoming covered with epithelium by 6 to 8 months following insertion, yet allowing easy removal within the first 4 to 6 weeks should the need arise. This technique provides a useful alternative to conventional surgical treatment in the high risk patient.

Entities:  

Mesh:

Year:  1990        PMID: 1697491     DOI: 10.1111/j.1464-410x.1990.tb14866.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  7 in total

Review 1.  Review of current and future approaches to the management of benign prostatic hyperplasia.

Authors:  J C Gingell
Journal:  Postgrad Med J       Date:  1992-09       Impact factor: 2.401

2.  Haemodynamic evidence for cardiac stress during transurethral prostatectomy.

Authors:  J W Evans; M Singer; C R Chapple; N Macartney; J M Walker; E J Milroy
Journal:  BMJ       Date:  1992-03-14

3.  How should new treatments for benign prostatic hyperplasia be assessed?

Authors:  D Kirk
Journal:  BMJ       Date:  1993-05-15

4.  Balloon dilatation of the prostate--should it have a place in the urologist's armamentarium?

Authors:  J A Vale; P D Miller; R S Kirby
Journal:  J R Soc Med       Date:  1993-02       Impact factor: 5.344

5.  Placement of retrievable self-expandable metallic stents with barbs into patients with obstructive prostate cancer.

Authors:  Ho-Young Song; Choung Soo Kim; In Gab Jeong; Dalsan Yoo; Jin Hyoung Kim; Deok Ho Nam; Jae-Ik Bae; Jung-Hoon Park
Journal:  Eur Radiol       Date:  2012-09-16       Impact factor: 5.315

Review 6.  Urethral stents in benign prostate hyperplasia.

Authors:  Robert F Donnell
Journal:  Curr Urol Rep       Date:  2003-08       Impact factor: 2.862

Review 7.  Use of prostatic stents for the treatment of benign prostatic hyperplasia in high-risk patients.

Authors:  J S Lam; M A Volpe; S A Kaplan
Journal:  Curr Urol Rep       Date:  2001-08       Impact factor: 2.862

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.